Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 23;12:1758835920937422. doi: 10.1177/1758835920937422

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Kaplan–Meier curves showing the mOS of patients with sorafenib-resistant advanced HCC treated with apatinib or supportive care.

HCC, hepatocellular carcinoma; mOS, median overall survival. The median OS times were 7.0 months (95% CI: 5.8, 8.2) for the apatinib group and 4.0 months (95% CI: 2.9, 5.1) for the supportive care group (p < 0.001).